2016 Canadian Conference on Ovarian Cancer Research: Intensify Innovation, Improve Impact

Michelle Hildebrandt

Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors

Ovary

Neil Johnson

Identifying BRCA1 protein variants that provide resistance to therapy

Ovary Breast

Eric Asselin

Gene therapy of chemoresistant and metastatic cancers (CANADA RESEARCH CHAIRHOLDER)

Ovary Corpus uteri

Alexi A Wright

Chemotherapy Near Death: Modifiable Factors and Outcomes in Ovarian Cancer

Ovary

E. Blair Holladay

Partners for Cancer Diagnostic and Treatment in Africa

Thyroid Ovary Cervix uteri Breast All cancers but non-melanoma skin cancer

Pathology

Jérôme Fortin

Genetic and functional dissection of PTEN tumor suppressor activity in high-grade ovarian serous carcinoma

Ovary

Alicia S Kunin-Batson

A novel approach into modeling origin and development of ovarian cancer

Ovary

David Komander

Specificity in the ubiquitin system

Ovary

Martin Mcintosh

Profiling cancer neoantigen repertoires and validating immunotherapy targets

Trachea, bronchus and lung Ovary Colorectum